Evidence map›Paper›PMID 32578383›Full record

ArticleThoracic cancer2020

Whole exome sequencing of lung adenocarcinoma and lung squamous cell carcinoma in one individual: A case report.

Yuxi Bai, Yinghui Xu, Xu Wang, Yunpeng Liu, Chao Sun, Ye Guo, Yangyang Cai, Guoguang Shao, Zhiguang Yang, Shi Qiu and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Thoracic cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yuxi BaiCancer Center, The First Hospital of Jilin University, Jilin, China.
Yinghui XuCancer Center, The First Hospital of Jilin University, Jilin, China.
Xu WangCancer Center, The First Hospital of Jilin University, Jilin, China.
Yunpeng LiuThoracic Surgery Department, The First Hospital of Jilin University, Jilin, China.
Chao SunCancer Center, The First Hospital of Jilin University, Jilin, China.
Ye GuoCancer Center, The First Hospital of Jilin University, Jilin, China.
Yangyang CaiCancer Center, The First Hospital of Jilin University, Jilin, China.
Guoguang ShaoThoracic Surgery Department, The First Hospital of Jilin University, Jilin, China.
Zhiguang YangThoracic Surgery Department, The First Hospital of Jilin University, Jilin, China.
Shi QiuCancer Center, The First Hospital of Jilin University, Jilin, China.
Kewei MaCancer Center, The First Hospital of Jilin University, Jilin, China.ORCID 0000-0003-2987-576X
Jilin University · CN

Funding

Xisike Clinical Oncology Research Foundation Y-HS2017-062Youth Foundation of The First Hospital of Jilin University JDYY82017020
6 · The paper itself

Abstract

Multiple primary lung cancers (MPLCs) refers to two or more primary malignant tumors that occur simultaneously or successively in the lung of the same patient. Distinguishing MPLCs from intrapulmonary metastases is important for treatment strategy and prognosis. MPLCs have been considered as having different origins and clonal evolutionary processes. Whole genome sequencing (WGS) and whole exome sequencing (WES) are regarded as an effective way to identify the relationship and differentiation among MPLC nodules. Here, we report the case of a 63-year-old MPLC male patient who smoked for 40 years. Two nodules were found on chest computed tomography (CT) scan, which were further confirmed by pathology to be lung adenocarcinoma (ADC) and lung squamous cell carcinoma (SCC), respectively. WES of the two different nodules was performed, and the results showed that there was a significant genetic difference between the two nodules. Further analysis of the tumor mutation burden (TMB) of the two tumor lesions showed that the TMB of the squamous cell carcinoma was higher than that of the adenocarcinoma, indicating that the squamous cell carcinoma had a higher mutation frequency. According to the pathology and WES sequencing results, MPLCs for this case were regarded as independent of each other, with different origins and clonal evolutionary processes. In this case report, we emphasize that WES should play an important role in determining the origin of MPLC clones, and also make some explorations for the further discovery of new potential driver genes and therapeutic targets.

Indexed as

Adenocarcinoma of LungCarcinoma, Squamous CellExome SequencingHumansLung NeoplasmsMaleMiddle AgedMultiple primary lung cancers (MPLCs)non-small cell lung cancer (NSCLC)whole exome sequencing (WES)

Identifiers

PMID32578383
PMCPMC7396389
OpenAlexW3037217619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.